PTNA logo

Monday 5 December 2016


The Paediatric Trials Network Australia (PTNA)

The Paediatric Trials Network Australia (PTNA) draws together paediatric researchers from around the country committed to improving child health through the facilitation of paediatric clinical trials. It is a not for profit, virtual and inclusive network that is open for membership to any paediatric research organisation dedicated to increasing the quality and quantity of paediatric research in Australia. 
The PTNA aims to:
  • provide a platform for advocacy for collaborative clinical research for paediatrics in Australia.
  • improve the Australian operating environment for paediatric clinical trials sponsored by industry.
  • increase the quality and quantity of investigator-driven paediatric trials.
  • strengthen the evidence base for the treatment of all children and adolescents.
Our funders and current members are:


 CHQHH logo          
 SA Health WCH mono stacked                       JHCH 2014 20percent                       Monash Childrens Hospital Logo 

About PTNA

Therapeutic Innovation Australia provided a federal grant as part of the National Collaborative Research Infrastructure Strategy to the PTNA to enable the development of WebSpirit. This Clinical Trials Data Management Software (CTDMS) system was launched in late 2013 and this system is now in use in a number of trials across Australia. This secure data management system is web-based and registered users can access it from anywhere in the world where internet is available. Find out more about WebSpirit on our WebSpirit page or by viewing our presentation below.

PTNA hopes its infrastructure and advocacy efforts can complement the activity of other other established paediatric research networks and benefit all paediatric researchers, and ultimately Australian children. We welcome enquiries from any researchers that may wish to collaborate through the PTNA and gain access to its infrastructure. 

PTNA is focused on the conduct of multi-centre paediatric studies (birth to 18 years) developed by researchers or industry partners across all therapeutic areas, in order to improve the health of our children. This may include randomised controlled trials with drugs, devices or other health interventions, as well as observational and health services research.

The network facilitates access to a critical mass of researchers and enough volunteers across the country that clinical trials can be successfully completed in a timely fashion, as well as provide infrastructure to speed up communication and data collection.